Clinical Trial Update: Treatment of Severe Acute Respiratory Distress Syndrome With Allogeneic Bone Marrow-derived Mesenchymal Stromal Cells [Phase 1]

View source ↗

Summary

This document reports on a Phase 1 trial evaluating the safety and feasibility of allogeneic bone marrow-derived mesenchymal stromal cells to treat adults with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Allogeneic bone marrow-derived mesenchymal stromal cells (bone marrow-derived mesenchymal stromal cells)

Snippet

Sponsor: Karolinska University Hospital | Conditions: Acute Respiratory Distress Syndrome, Adult | Phase 1 | Status: UNKNOWN